Adamczyk M, Zwierzchowski G, Malicki J, et al. (2013) Evaluation of clinical benefits achievable by using different optimization algorithms during real-time prostate brachytherapy. Physica Medica 29: 111–6

Batchelar DL, Law N, Cisecki T, Loblaw DA, Chung H, Morton GC (2011). Does Intraoperative Ultrasound-Based Planning for HDR Prostate Brachytherapy Reduce Needle Displacement? Brachytherapy 10, Supplement 1(0): S92

Cancer Research UK (2014a) Prostate cancer key facts [accessed September 2014]

Cancer Research UK (2014b) Internal radiotherapy (brachytherapy) for prostate cancer [accessed September 2014]

Challapalli A, Robinson A, Dunn P, et al. (2011) Image guided HDR brachytherapy boost for locally advanced prostate cancer using OnCentra™ prostate HDR planning system Clinical Oncology. Conference: UK Radiation Oncology Conference 2011 Manchester United Kingdom. Conference Publication: 23 (3) (pp S14), 2011

Choudhury A, Arthur C, Malik J, et al. (2014) Patient-reported Outcomes and Health-related Quality of Life in Prostate Cancer Treated with a Single Fraction of High Dose Rate Brachytherapy Combined with Hypofractionated External Beam Radiotherapy. Clinical Oncology; in‑press

Curtis L (2013) PSSRU: Unit Costs of Health & Social Care 2013

Drummond M, Sculpher M, Torrance G, et al. (2005) Methods for economic health evaluation of health care programmes (3rd ed.) Oxford University Press

Filipowski TM, Szmigiel-Trzcinska A, Topczewska-Bruns J, et al. (2012) Efficacy, toxicity and dosimetric aspects of HDR brachytherapy in prostate cancer patients: 5 years experience.Radiotherapy and Oncology. Conference: World Congress of Brachytherapy, Barcelona Spain. Conference Publication: 103 (pp S72), 2012

Gomez-Iturriaga A, Crook J, Casquero F et al. (2014) Impact of intraoperative MRI/TRUS fusion on dosimetric parameters in cT3a prostate cancer patients treated with high-dose-rate real-time brachytherapy. Journal of Contemporary Brachytherapy 6(2): 154–160

Kabacinska R, Terlikiewicz J, Lasota J, et al. (2013) Evaluation of dosimetric parameters in prostate high-dose-rate brachytherapy: Applicability of anatomybased inverse optimization and graphic optimization. European Urology, Supplements 12 (6): 162

Kanikowski M (2013) Comparison of treatment plan parameters in brachytherapy of prostate cancer in different schedules. Brachytherapy. Conference: 34th Annual Meeting of the American Brachytherapy Society, ABS 2013 New Orleans, LA United States. Conference Publication: 12 (pp S64), 2013

Kunhiparambath H, Laviraj MA, Rath GK, et al. (2011) A comparative analysis of single objective dose volume histogram (SDVHO)-based inverse planning optimization versus volume-based geometric optimization in real-time prostate brachytherapy planning with OnCentra™ Prostate. Journal of Clinical Oncology. Conference: ASCO Annual Meeting 2011 Chicago, IL United States. Conference Publication: 29 (15 SUPPL. 1), 2011.

Laviraj MA, Rath GK, Kunhiparambath H, et al. (2011) Multisolution variance-based optimization (MVBO) versus multisolutions dose volume histogram-based optimization (MDVHO): A comparative analysis of anatomy-based multisolution blind inverse planning optimizations in OnCentra™Prostate. Journal of Clinical Oncology. Conference: ASCO Annual Meeting 2011 Chicago, IL United States. Conference Publication: 29 (15 SUPPL. 1), 2011

Milickovic N, Mavroidis P, Tselis N, Nikolova I, Katsilieri Z, Kefala V, Zamboglou N, Baltas D (2011) 4D analysis of influence of patient movement and anatomy alteration on the quality of 3D U/S-based prostate HDR brachytherapy treatment delivery. Medical Physics 38(9): 4982–93

Pi Medical (2014) Product development [accessed September 2014]

Pokharel S, Rana S, Blikenstaff J, et al. (2012) Evaluation of hybrid inverse planning and optimization (HIPO) algorithm for optimization in real-time, high-dose-rate (HDR) brachytherapy for prostate. Journal of Applied Clinical Medical Physics 14(4): 4198

Schwarz R, Thurmann H, Lambert J, Frenzel T, Platz V, Petersen C, Krüll A (2010) Implementation of a new brachytherapy planning and delivery system in the daily routine of HDR-brachytherapy of prostate cancer. Strahlentherapie Onkologie 186(1): 148

Sedgwick P (2012) Multiple significance tests: the Bonferroni correction. British Medical Journal 344: e509

van Tol-Geerdink JJ, Stalmeier PFM, Pasker-de Jong PCM, Huizenga H, van Lin E, Schimmel C, Leer JW, van Daal W (2006).Systematic review of the effect of radiation dose on tumor control and morbidity in the treatment of prostate cancer by 3D-CRT. International Journal of Radiation Oncology Biology Physics 64(2): 534–43